A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic Institute (RPI), the University of Nebraska Medical Center (UNMC), ...
Please provide your email address to receive an email when new articles are posted on . Adverse events reported with ENV-101 have been seen with other hedgehog inhibitors. Another trial is already ...
Researchers at University of California San Diego School of Medicine and Mayo Clinic provide the first evidence that the Hedgehog signaling pathway is central to the formation of gastrointestinal ...
Analysis of effectiveness of FLOT perioperative chemotherapy in resectable locally advanced gastric or esophago-gastric junction cancer in a Kazakhstani population. Efficacy and safety of donafenib ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, ...
Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul ...
Colorectal cancer often returns not because the main tumor survives, but because a small population of stem-like cancer cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results